MedPath

Counseling to improve adherence to the taking of medications for tuberculosis in Bali, Indonesia

Not Applicable
Completed
Conditions
Medication adherence and treatment success in patients with tuberculosis
Infections and Infestations
Registration Number
ISRCTN18141422
Lead Sponsor
dayana University
Brief Summary

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34948846/ (added 16/02/2022)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
214
Inclusion Criteria

For the interventional trial:
1. New patients who are diagnosed with early pulmonary TB based on records registered with TB in the health center and have never received OAT
2. Patients diagnosed with pulmonary tuberculosis, the treatment has not yet passed the two-month treatment period (intensive phase), seen from the records in the public health center TB register
3. Based on the register, the patient was diagnosed with pulmonary TB through a bacteriological examination (positive smear) using the Molecular Rapid Test (TCM)
4. Adult patients aged 18 - 65 years

For qualitative data collection:
1. Patients who have received HBM-based MI intervention
1.1. Non-compliance with taking medication
1.2. Failure in treatment
1.3. Able to communicate well and willing to be informants.
1.4. Own and be able to use a smartphone
1.5. Willing to be interviewed using online media via telephone/video call for approximately 30 minutes
2. Officer/counsellor
2.1. Easy contact to communicate
2.2. Own and be able to use a smartphone
2.3. Able to communicate well and willing to be informants
2.4. Willing to be interviewed using online media via telephone/video call for approximately 30 minutes

Exclusion Criteria

For interventional trial:
1. MDR TB patients who are registered in the TB register
2. Have other comorbidities such as diabetes mellitus, cirrhosis of the liver, hepatitis; cardiovascular disease based on the doctor's examination on the TB register
3. Patients are not willing to follow Tuberculosis treatment until the advanced phase
4. Families of sufferers do not have/are unable to use a smartphone

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath